8-K filing — American Healthcare REIT, Inc. (AHR)
Filed: 2026-08-24 AccNo: 0001193125-26-363616 Size: 1 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 21, 2026, 11:58 AM
- Checked
- Jul 21, 2026, 11:58 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Keybanc Maintains Overweight on American Healthcare REIT, Raises Price Target to $68
Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $58 to $68.
Read original at benzingaTruist Securities Maintains Buy on American Healthcare REIT, Raises Price Target to $61
Truist Securities analyst Michael Lewis maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $57 to $61.
Read original at benzingaRBC Capital Maintains Outperform on American Healthcare REIT, Raises Price Target to $61
RBC Capital analyst Michael Carroll maintains American Healthcare REIT (NYSE:AHR) with a Outperform and raises the price target from $56 to $61.
Read original at benzingaMizuho Maintains Outperform on Axsome Therapeutics, Raises Price Target to $316
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and raises the price target from $306 to $316.
Read original at benzingaMorgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $251
Morgan Stanley analyst Sean Laaman maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $242 to $251.
Read original at benzinga